Back to search

Article

Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinoma

2022-03-30

Abstract excerpt

<h4>Background: </h4> Resistance to targeted therapies represents a major hurdle to successfully treat hepatocellular carcinoma (HCC). While epigenetic abnormalities are critical determinants of HCC relapse and therapeutic resistance, the underlying mechanisms are poorly understood. We aimed to address whether and how dysregulated epigenetic regulators have regulatory and functional communications in establishing...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7041ef8-216b-5f98-a6dd-f225efcd57c4
DOI
10.21203/rs.3.rs-1432174/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Coordinated activation of DNMT3a and TET2 in cancer stem cell-like cells initiates and sustains drug resistance in hepatocellular carcinomaDOI 10.21203/rs.3.rs-1432174/v2
Select a neighboring publication to make it the new centre.